InflaRx IFRX
NASDAQ IFRX
$1.53 -0.02 (-1.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

InflaRx (IFRX) Non-Current Deffered Revenue (2017 - 2019)

Updated

InflaRx (IFRX) reported Non-Current Deffered Revenue of $8,951 for Q3 2019, down 11.5% from the prior quarter.

Analysis

InflaRx (IFRX) Non-Current Deffered Revenue (2017 - 2019) Analysis & Trends

At the end of FY2018, InflaRx posted Non-Current Deffered Revenue of $12,755, down 24.7% from FY2017.

  • By year, Non-Current Deffered Revenue came in at $16,940 in FY2017.
  • Per Business Quant data, the three quarters before Q3 2019 came in at $10,113 (Q2 2019), $11,366 (Q1 2019) and $12,324 (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 InflaRx 103.29 Mn -230.33 Mn 2.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 8,802.32
Jun 30, 2019 10,235.65
Mar 31, 2019 11,230.02
Dec 31, 2018 12,351.71
Dec 31, 2017 17,912.59
API Access

InflaRx Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IFRX&period=max&api_key=YOUR_API_KEY